Continuous Glucose Monitoring (CGM) in GDM management

Type: device

Status: FDA Approved (for general diabetes, increasingly used off-label/guideline for GDM)

Developer: Dexcom, Abbott

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026